Th17 cells in the setting of Aspergillus infection and pathology

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Zelante, Teresa ^a   Bozza, Silvia ^a   de Luca, Antonella ^a   D'Angelo, Carmen ^a   Bonifazi, Pierluigi ^a   Moretti, Silvia ^a   Giovannini, Gloria ^a   Bistoni, Francesco ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Aspergillus; Indoleamine 2,3 dioxygenase; Inflammation; Regulatory T cells; Th17 cells

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 6; KYNURENINE; PENTRAXIN 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; INTERLEUKIN 23P19;

ADAPTIVE IMMUNITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; POLYMORPHONUCLEAR CELL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; IMMUNOLOGY; MOUSE; PATHOLOGY; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; MICE; T-LYMPHOCYTE SUBSETS;

EID: 67651122076     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802140766     Document Type: Article

References (69)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
2. Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16 875-894, vi.
3. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007; 127: 349-355.
4. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
5. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 654-662.
6. Cenci E, Mencacci A, Fe d'Ostiani C, et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750-1760.
7. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defences against Aspergillus fumigatus. Res Immunol 1998; 149: 454-465; discussion 523-524.
8. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451: 211-215.
9. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401.
10. Miceli MH, Maertens J, Buve K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer 2007; 110: 112-120.
11. Shelburne SA, 3rd, Darcourt J, White AC, Jr., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-1052.
12. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004 4 1-23.
13. Bellocchio S, Moretti S, Perruccio K, et al. TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173: 7406-7415.
14. Moretti S, Bellocchio S, Bonifazi P, et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 2008; 1: 156-168.
15. Bignell E, Negrete-Urtasun S, Calcagno AM, et al. Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/-mice. Infect Immun 2005; 73 5204-5207.
16. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
17. Bellocchio S, Montagnoli C, Bozza S, et al. The Contribution of the Toll-Like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-3069.
18. Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002; 4 1281-1290.
19. Bretz C, Gersuk G, Knoblaugh S, et al. Myd88-signaling contributes to early plmonary responses to Aspergillus fumigatus. Infect Immun 2008; 76: 952-958.
20. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Tolllike receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124: 238-243.
21. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004; 12: 44-49.
22. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 2008; 7: 204-208.
23. Rose NR. The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol 2008. Jan 4. [Epub ahead of print]
24. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337-366.
25. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
26. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182-186.
27. Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362-1371.
28. Cenci E, Mencacci A, Bacci A, et al. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000; 165: 381-388.
29. Holt PG, Stumbles PA, McWilliam AS. Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leukoc Biol 1999; 66: 272-275.
30. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-731.
31. Bozza S, Perruccio K, Montagnoli C, et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003; 102: 3807-3814.
32. Montagnoli C, Perruccio K, Bozza S, et al. Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. Blood Cells Mol Dis 2008; 40: 55-62.
33. Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006; 108: 2265-2274.
34. Montagnoli C, Fallarino F, Gaziano R, et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006; 176: 1712-1723.
35. Romani L, Puccetti P. Protective tolerance to fungi: The role of IL-10 and tryptophan catabolism. Trends Microbiol 2006; 14: 183-189.
36. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: Much ado about IDO. Trends Immunol 2003; 24: 242-248.
37. Grohmann U, Volpi C, Fallarino F, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007; 13: 579-586.
38. Puccetti P, Grohmann U. IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007; 7: 817-823.
39. Belkaid Y. Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 2007; 7: 875-888.
40. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801-805.
41. Hohl TM, Rivera A, Pamer EG. Immunity to fungi. Curr Opin Immunol 2006; 18: 465-472.
42. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
43. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240.
44. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19: 281-286.
45. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24 179-189.
46. Dong C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6: 329-333.
47. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 2006; 18: 349-356.
48. Romani L, Puccetti P. Controlling pathogenic inflammation to fungi. Expert Rev Anti Infect Ther 2007; 5: 1007-1017.
49. Yang XO, Pappu BP, Nurieva R, et al. T Helper 17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and RORgamma. Immunity 2008; 28: 29-39.
50. Happel KI, Dubin PJ, Zheng M, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005; 202: 761-769.
51. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5: 521-531.
52. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
53. Bettelli E, Kuchroo VK. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 2005; 201 169-171.
54. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity 2003; 19: 641-644.
55. Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-2706.
56. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527.
57. Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25: 159-172.
58. Smith E, Zarbock A, Stark MA, et al. IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol 2007; 179: 8274-8279.
59. Becker C, Dornhoff H, Neufert C, et al. Cutting edge: IL-23 crossregulates IL-12 production in T cell-dependent experimental colitis. J Immunol 2006; 177: 2760-2764.
60. Cenci E, Mencacci A, Casagrande A, et al. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin- 6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 2001; 184: 610-617.
61. Bozza S, Zelante T, Moretti S, et al. Lack of Toll IL-1R 8 Exacerbates Th17 cell responses in fungal infection. J Immunol 2008; 180: 4022-4031.
62. Bozza S, Fallarino F, Pitzurra L, et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 2005; 174: 2910-2918.
63. Kalo-Klein A, Witkin SS. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun 1990; 58: 260-262.
64. Mellor AL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.
65. Mencacci A, Spaccapelo R, Del Sero G, et al. CD4+T-helper-cell responses in mice with low-level Candida albicans infection. Infect Immun 1996; 64: 4907-4914.
66. De Luca A, Montagnoli C, Zelante T, et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007; 179: 5999-6008.
67. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176: 6752-6761.
68. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170-200.
69. Romani L, Puccetti P. Immune regulation and tolerance to fungi in the lungs and skin. Chem. Immunol In press.